Viewing Study NCT02918318


Ignite Creation Date: 2025-12-25 @ 4:56 AM
Ignite Modification Date: 2026-04-16 @ 6:23 PM
Study NCT ID: NCT02918318
Status: COMPLETED
Last Update Posted: 2025-04-29
First Post: 2016-09-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression
Sponsor: Janssen Pharmaceutical K.K.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Depression View
Keywords: